Pengcheng Zhou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Signaling Pathway

Cell Proliferation

Top Venues

Cell death & disease

Biomaterials research

This page only lists publications with an associated author ORCID identifier.

Publications

Pengcheng Zhou, Xian'guang Ding, Xuanlong Du, Lian-Hui Wang, Yewei Zhang
Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment. Biomaterials research 28 (2024)
Pengcheng Zhou, Xian'guang Ding, Xuanlong Du, Lian-Hui Wang, Yewei Zhang
Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment. Biomaterials research 28 (2024)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)